Status:
COMPLETED
Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty
Lead Sponsor:
NYU Langone Health
Conditions:
Rhinoplasty
Non-steroidal Ant Inflammatory Drugs
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This...
Eligibility Criteria
Inclusion
- Patients 18-70 years old undergoing septorhinoplasty or rhinoplasty for either obstructive or aesthetic reasons. All approaches to rhinoplasty and surgical techniques utilized will be included. This will include patients that undergo additional procedures during the rhinoplasty including osteotomies, turbinate reduction, septoplasty, nasal valve repair and ear cartilage graft.
Exclusion
- Patients who undergo a rhinoplasty requiring a rib cartilage graft for the procedure as this is known to cause significant pleuritic chest pain.
- Patients receiving functional endoscopic sinus surgery concurrently with the rhinoplasty will be excluded.
- Patients with known history of gastrointestinal bleeds, peptic ulcer disease or who have other comorbidities that prevent them from taking NSAIDs.
- Patients with a history of radiation, active head and neck malignancy or other pain disorders such as various rheumatologic diseases will be excluded to decrease confounding factors in the control of pain.
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03457116
Start Date
January 30 2018
End Date
November 2 2020
Last Update
November 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Medical Center
New York, New York, United States, 10016